Fertility options in transgender people

Abstract Hormonal and surgical treatments for transgender people have a devastating effect on the possibility for these patients to reproduce. Additionally, transgender people tend to start sex reassignment treatment at a young age, when reproductive wishes are not yet clearly defined nor fulfilled. The most recent Standards of Care of the World Professional Association for Transgender Health recommend clearly informing patients regarding their future reproductive options prior to initiation of treatment. This review gives an overview of the current knowledge and state-of-the-art techniques in the field of fertility preservation for transgender people. Where genital reconstructive surgery definitely results in sterility, hormone therapy on the other hand also has an important, but partially reversible impact on fertility. The current fertility preservation options for trans men are embryo cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation. For trans women, sperm cryopreservation, surgical sperm extraction and testicular tissue cryopreservation are possible. Although certain fertility preservation techniques could be applicable in a standardized manner based on clear biological criteria, the technique that eventually will be performed should be the preferred choice of the patient after extended explanation of all possible options.

[1]  A. Agarwal,et al.  Semen characteristics of transwomen referred for sperm banking before sex transition: a case series , 2015, Andrologia.

[2]  E. Coleman,et al.  Principles of Transgender Medicine and Surgery , 2015 .

[3]  T. Murphy.  Assisted Gestation and Transgender Women , 2015, Bioethics.

[4]  B. Kreukels,et al.  Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. , 2015, Fertility and sterility.

[5]  Milan Milenkovic,et al.  Livebirth after uterus transplantation , 2015, The Lancet.

[6]  Juno Obedin-Maliver,et al.  Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning , 2014, Obstetrics and gynecology.

[7]  L. Kondapalli,et al.  Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[8]  C. Dhejne,et al.  Preserving eggs for men’s fertility. a pilot experience with fertility preservation for female-to-male transsexuals in sweden , 2014 .

[9]  John B Steever.  Cross-gender hormone therapy in adolescents. , 2014, Pediatric annals.

[10]  Richard A. Anderson,et al.  The physiology and clinical utility of anti-Mullerian hormone in women. , 2014, Human reproduction update.

[11]  B. Heindryckx,et al.  Use of pluripotent stem cells for reproductive medicine: are we there yet? , 2014, The Veterinary quarterly.

[12]  G. T’Sjoen,et al.  Transgenderism and reproduction , 2013, Current opinion in endocrinology, diabetes, and obesity.

[13]  B. Golse,et al.  A new type of family: Transmen as fathers thanks to donor sperm insemination. A 12-year follow-up exploratory study of their children , 2013 .

[14]  A. Agarwal,et al.  Sperm Freezing in Transsexual Women , 2012, Archives of Sexual Behavior.

[15]  W. J. Meyer,et al.  Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 , 2012 .

[16]  T. Murphy.  The Ethics of Fertility Preservation in Transgender Body Modifications , 2012, Journal of Bioethical Inquiry.

[17]  G. Pennings,et al.  Reproductive wish in transsexual men. , 2012, Human reproduction.

[18]  R. Fanchin,et al.  Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. , 2010, Reproductive biomedicine online.

[19]  W. J. Meyer,et al.  The Ultrastructural Response of Human Leydig Cells to Exogenous Estrogens , 2009, Andrologia.

[20]  T. White,et al.  Adaptation and adjustment in children of transsexual parents , 2007, European Child & Adolescent Psychiatry.

[21]  T. White,et al.  Disclosure, Risks and Protective Factors for Children Whose Parents Are Undergoing a Gender Transition , 2004 .

[22]  P. Sutter,et al.  The desire to have children and the preservation of fertility in transsexual women: A survey. , 2002 .

[23]  R. Van den Broecke,et al.  Follicular growth in fresh and cryopreserved human ovarian cortical grafts transplanted to immunodeficient mice. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[24]  P. Sutter.  Gender reassignment and assisted reproduction Present and future reproductive options for transsexual people , 2001 .

[25]  H. Lübbert,et al.  Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male. , 1992, Fertility and sterility.

[26]  L. Gooren,et al.  Ovarian morphology in long‐term androgen‐treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? , 1991, Histopathology.

[27]  J. G. van den Tweel,et al.  The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. , 1989, The Journal of clinical endocrinology and metabolism.

[28]  R. Green,et al.  Sexual identity of 37 children raised by homosexual or transsexual parents. , 1978, The American journal of psychiatry.

[29]  C. Schulze.  Response of the human testis to long-term estrogen treatment: Morphology of Sertoli cells, Leydig cells and spermatogonial stem cells , 2004, Cell and Tissue Research.

[30]  P. de Sutter.  Gender reassignment and assisted reproduction: present and future reproductive options for transsexual people. , 2001, Human reproduction.

[31]  O. Hovatta,et al.  The female-to-male transsexual patient: a source of human ovarian cortical tissue for experimental use. , 2001, Human reproduction.